Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02213926
Brief Title: An Open-label, Phase 2 Study of ACP-196 (Acalabrutinib) in Subjects With Mantle Cell Lymphoma

First Submitted : August 5, 2014
First Submitted that Met QC Criteria : August 11, 2014
First Posted : August 12, 2014 (Estimate)

Results First Submitted : August 16, 2018
Results First Submitted that Met QC Criteria : October 18, 2018
Results First Posted : October 19, 2018

Last Update Submitted that Met QC Criteria : June 26, 2019
Last Update Posted : July 10, 2019